NDC properties for NDC 9 54436-200
NDC item 54436020001
NDC 9 | 54436-200 |
---|---|
NDC 10 | 54436-200-01 |
NDC Item | 54436020001 |
packaging | 1 SYRINGE in 1 CARTON (54436-200-01) / .5 mL in 1 SYRINGE (54436-200-03) |
DCSA | CIII |
FDA SPL set id | 760387 |
Labeler | Antares Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2018-11-15 |
Marketing status | ACTIVE |
NDA | NDA209863 |
NDC item 54436020002
NDC 9 | 54436-200 |
---|---|
NDC 10 | 54436-200-02 |
NDC Item | 54436020002 |
packaging | 0.5 mL in 1 SYRINGE |
DCSA | CIII |
FDA SPL set id | 760387 |
Labeler | Antares Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2018-11-15 |
Marketing status | ACTIVE |
NDA | NDA209863 |
NDC item 54436020003
NDC 9 | 54436-200 |
---|---|
NDC 10 | 54436-200-03 |
NDC Item | 54436020003 |
packaging | 0.5 mL in 1 SYRINGE |
DCSA | CIII |
FDA SPL set id | 760387 |
Labeler | Antares Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2018-11-15 |
Marketing status | ACTIVE |
NDA | NDA209863 |
NDC item 54436020004
NDC 9 | 54436-200 |
---|---|
NDC 10 | 54436-200-04 |
NDC Item | 54436020004 |
packaging | 4 SYRINGE in 1 CARTON (54436-200-04) / .5 mL in 1 SYRINGE (54436-200-02) |
DCSA | CIII |
FDA SPL set id | 760387 |
Labeler | Antares Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2018-11-15 |
Marketing status | ACTIVE |
NDA | NDA209863 |
NDC item 54436020005
NDC 9 | 54436-200 |
---|---|
NDC 10 | 54436-200-05 |
NDC Item | 54436020005 |
packaging | 1 SYRINGE in 1 CARTON (54436-200-05) / .5 mL in 1 SYRINGE (54436-200-02) |
DCSA | CIII |
FDA SPL set id | 760387 |
Labeler | Antares Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | NDA |
Marketing effective time low | 2018-11-15 |
Marketing status | ACTIVE |
NDA | NDA209863 |